Lipocine Inc. statistics & valuation
P / B1.4×
Net margin-487.1%
Return on capital-71.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Net margin (%)Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Operating margin | -524.7% | -10.3% | 629.0% | -2423.9% | 19.5% | — | -7818.8% | -2646.0% | — | — |
| Net margin | -487.1% | 0.1% | 573.6% | -2151.7% | -3.9% | — | -7883.7% | -2724.1% | — | — |
| FCF margin | — | -11.7% | 416.7% | -2420.5% | -27.4% | — | — | -2822.0% | — | — |
| Return on assets | -56.6% | 0.0% | -71.1% | -28.7% | -1.2% | -82.7% | -66.2% | -55.9% | -82.9% | -69.4% |
| Return on equity | -66.5% | 0.0% | -80.3% | -30.2% | -1.4% | -136.7% | -206.9% | -123.6% | -110.6% | -72.9% |
| Debt / equity | — | — | — | — | 0.04× | 0.33× | 1.06× | 1.06× | 0.00× | — |
| Current ratio | 6.68 | 14.75 | 8.69 | 20.34 | 8.26 | 3.85 | 3.95 | 4.63 | 3.97 | 20.52 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.